Ad is loading...
MCK
Price
$628.27
Change
+$7.13 (+1.15%)
Updated
Nov 21 closing price
68 days until earnings call
PDCO
Price
$20.28
Change
+$0.22 (+1.10%)
Updated
Nov 21 closing price
13 days until earnings call
Ad is loading...

MCK vs PDCO

Header iconMCK vs PDCO Comparison
Open Charts MCK vs PDCOBanner chart's image
McKesson
Price$628.27
Change+$7.13 (+1.15%)
Volume$499.09K
CapitalizationN/A
Patterson Companies
Price$20.28
Change+$0.22 (+1.10%)
Volume$681.21K
CapitalizationN/A
MCK vs PDCO Comparison Chart
Loading...
MCK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PDCO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MCK vs. PDCO commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCK is a Buy and PDCO is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (MCK: $628.27 vs. PDCO: $20.28)
Brand notoriety: MCK: Notable vs. PDCO: Not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MCK: 50% vs. PDCO: 85%
Market capitalization -- MCK: $70.55B vs. PDCO: $2.48B
MCK [@Medical Distributors] is valued at $70.55B. PDCO’s [@Medical Distributors] market capitalization is $2.48B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCK’s FA Score shows that 4 FA rating(s) are green whilePDCO’s FA Score has 1 green FA rating(s).

  • MCK’s FA Score: 4 green, 1 red.
  • PDCO’s FA Score: 1 green, 4 red.
According to our system of comparison, MCK is a better buy in the long-term than PDCO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCK’s TA Score shows that 5 TA indicator(s) are bullish while PDCO’s TA Score has 4 bullish TA indicator(s).

  • MCK’s TA Score: 5 bullish, 4 bearish.
  • PDCO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MCK is a better buy in the short-term than PDCO.

Price Growth

MCK (@Medical Distributors) experienced а +2.97% price change this week, while PDCO (@Medical Distributors) price change was +3.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.80%. For the same industry, the average monthly price growth was -0.85%, and the average quarterly price growth was -12.32%.

Reported Earning Dates

MCK is expected to report earnings on Jan 29, 2025.

PDCO is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Medical Distributors (+2.80% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($70.5B) has a higher market cap than PDCO($2.48B). MCK has higher P/E ratio than PDCO: MCK (24.25) vs PDCO (13.32). MCK YTD gains are higher at: 36.184 vs. PDCO (-25.704). MCK has higher annual earnings (EBITDA): 4.44B vs. PDCO (384M). MCK has more cash in the bank: 1.98B vs. PDCO (124M). PDCO has less debt than MCK: PDCO (895M) vs MCK (7.61B). MCK has higher revenues than PDCO: MCK (302B) vs PDCO (6.57B).
MCKPDCOMCK / PDCO
Capitalization70.5B2.48B2,846%
EBITDA4.44B384M1,156%
Gain YTD36.184-25.704-141%
P/E Ratio24.2513.32182%
Revenue302B6.57B4,599%
Total Cash1.98B124M1,598%
Total Debt7.61B895M850%
FUNDAMENTALS RATINGS
MCK vs PDCO: Fundamental Ratings
MCK
PDCO
OUTLOOK RATING
1..100
2464
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
659
SMR RATING
1..100
9951
PRICE GROWTH RATING
1..100
1579
P/E GROWTH RATING
1..100
1786
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDCO's Valuation (8) in the Medical Distributors industry is in the same range as MCK (18). This means that PDCO’s stock grew similarly to MCK’s over the last 12 months.

MCK's Profit vs Risk Rating (6) in the Medical Distributors industry is somewhat better than the same rating for PDCO (59). This means that MCK’s stock grew somewhat faster than PDCO’s over the last 12 months.

PDCO's SMR Rating (51) in the Medical Distributors industry is somewhat better than the same rating for MCK (99). This means that PDCO’s stock grew somewhat faster than MCK’s over the last 12 months.

MCK's Price Growth Rating (15) in the Medical Distributors industry is somewhat better than the same rating for PDCO (79). This means that MCK’s stock grew somewhat faster than PDCO’s over the last 12 months.

MCK's P/E Growth Rating (17) in the Medical Distributors industry is significantly better than the same rating for PDCO (86). This means that MCK’s stock grew significantly faster than PDCO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCKPDCO
RSI
ODDS (%)
Bearish Trend 2 days ago
44%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 5 days ago
69%
Declines
ODDS (%)
Bearish Trend 8 days ago
46%
Bearish Trend 3 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
62%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
55%
View a ticker or compare two or three
Ad is loading...
MCK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PDCO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VST166.6111.98
+7.75%
Vistra Corp
DXC21.820.65
+3.07%
DXC Technology Company
TWIN11.170.10
+0.90%
Twin Disc
FNA10.430.08
+0.77%
Paragon 28
CVKD14.01-0.49
-3.38%
Cadrenal Therapeutics Inc

MCK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCK has been loosely correlated with COR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if MCK jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCK
1D Price
Change %
MCK100%
+1.15%
COR - MCK
59%
Loosely correlated
+1.02%
CAH - MCK
50%
Loosely correlated
+2.56%
SHTDF - MCK
9%
Poorly correlated
N/A
OMI - MCK
4%
Poorly correlated
+2.86%
PDCO - MCK
-0%
Poorly correlated
+1.10%
More

PDCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDCO has been loosely correlated with HSIC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if PDCO jumps, then HSIC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDCO
1D Price
Change %
PDCO100%
+1.10%
HSIC - PDCO
55%
Loosely correlated
+0.05%
OMI - PDCO
17%
Poorly correlated
+2.86%
ZYXI - PDCO
15%
Poorly correlated
+3.18%
CAH - PDCO
14%
Poorly correlated
+2.56%
COR - PDCO
12%
Poorly correlated
+1.02%
More